FDA Clears Parker’s Indego® Exoskeleton for Clinical, Personal Use
Go back to FDA Clears Parker’s Indego® Exoskeleton for Clinical, Personal Use| Parker-Hannifin (NYSE: PH) | Delayed: 1001.74 +1.61 (0.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1000.13 | 52 Week High | $139.73 | |||
| Open | $1010.01 | 52 Week Low | $83.32 | |||
| Day High | $1012.16 | P/E | 148.41 | |||
| Day Low | $993.52 | EPS | $6.75 | |||
| Volume | 545,475 | |||||
